endangering patients,” said the FTC's Chair, Lina Khan. “Our inquiry requests information on the factors driving these shortages and scrutinises the practices of opaque drug middlemen.” ...
The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...
Evidence also suggests that some of the prescription drug rebates negotiated ... “I’m proud that the FTC launched a bipartisan investigation into these shadowy middlemen, and its preliminary ...